| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0748233708094188 |
| P698 | PubMed publication ID | 19028774 |
| P2093 | author name string | J Taylor | |
| N Roney | |||
| A Ashizawa | |||
| O Faroon | |||
| D J Plewak | |||
| M H Lumpkin | |||
| P2860 | cites work | Synergistic inactivation of plasma alpha1-proteinase inhibitor by aldehydes of cigarette smoke with styrene oxide and 1,2-dichloroethane | Q23912909 |
| Interactions of sulfur dioxide and acrolein as sensory irritants | Q23916746 | ||
| Sensory irritation to formaldehyde and acrolein during single and repeated exposures in mice | Q23916747 | ||
| Mutagenesis by acrolein-derived propanodeoxyguanosine adducts in human cells | Q31118236 | ||
| Cytotoxicity, thiol depletion and inhibition of O6-methylguanine-DNA methyltransferase by various aldehydes in cultured human bronchial fibroblasts | Q31958359 | ||
| Sulfidopeptide leukotrienes mediate acrolein-induced bronchial hyperresponsiveness | Q46701671 | ||
| Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins | Q47954956 | ||
| Formation, toxicity and inactivation of acrolein during biotransformation of cyclophosphamide as studied in freshly isolated cells from rat liver and kidney | Q49226790 | ||
| Mutagenic activity of acrolein in S. typhimurium and E. coli | Q50139979 | ||
| Application of an immunoassay for cyclic acrolein deoxyguanosine adducts to assess their formation in DNA of Salmonella typhimurium under conditions of mutation induction by acrolein | Q50196659 | ||
| Evaluation of the SOS chromotest | Q50198171 | ||
| The pathologic and immunologic effects of inhaled acrolein in rats | Q50200046 | ||
| Naturally occurring carbonyl compounds are mutagens in Salmonella tester strain TA104. | Q50206721 | ||
| Non-mutagenicity of 27 aliphatic acrylate esters in the Salmonella-microsome test | Q50207811 | ||
| Mutagenic properties of allylic and alpha, beta-unsaturated compounds: consideration of alkylating mechanisms | Q50212796 | ||
| Studies on mutagenic constituents of apple brandy and various alcoholic beverages collected in western France, a high incidence area for oesophageal cancer | Q50217224 | ||
| Screening of tobacco smoke constituents for mutagenicity using the Ames' test | Q50220070 | ||
| Mutagenicity of vinyl compounds in salmonella typhimurium | Q50220492 | ||
| Evaluation of herbicides for possible mutagenic properties | Q50236836 | ||
| Metabolism and distribution of [2,3-14C]acrolein in Sprague-Dawley rats. | Q50996645 | ||
| Risk assessment extrapolations and physiological modeling. | Q51819085 | ||
| Chemical mutagenesis testing in Drosophila. II. Results of 20 coded compounds tested for the National Toxicology Program. | Q52466144 | ||
| Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. | Q52604250 | ||
| Detection of chemical mutagens by the dominant lethal assay in the mouse | Q52966412 | ||
| Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. | Q53226236 | ||
| Acrolein mutagenicity in the V79 assay. | Q53509238 | ||
| Chronic carcinogenesis studies of acrolein and related compounds. | Q53527334 | ||
| Selected responses of hypertension-sensitive and resistant rats to inhaled acrolein. | Q54474694 | ||
| The effects of acrolein exposure on pulmonary antibacterial defenses. | Q54503959 | ||
| EFFECT OF POSSIBLE SMOG IRRITANTS ON HUMAN SUBJECTS | Q56636670 | ||
| Permeability and vascularity of the developing brain: cerebellum vs cerebral cortex | Q34056357 | ||
| Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period | Q34062843 | ||
| Fetus-specific expression of a form of cytochrome P-450 in human livers | Q34625653 | ||
| Phytoestrogens: epidemiology and a possible role in cancer protection | Q34831826 | ||
| Evidence for increasing incidence of abnormalities of the human testis: a review | Q34848445 | ||
| Protein-bound acrolein: potential markers for oxidative stress | Q36058528 | ||
| Review and analysis of inhalation dosimetry methods for application to children's risk assessment | Q36131290 | ||
| Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsatu | Q37363040 | ||
| A critical review of the literature on acrolein toxicity | Q38591485 | ||
| Comparison of Protection byl-ascorbic acid,l-cysteine, and adrenergic-blocking agents against acetaldehyde, acrolein, and formaldehyde toxicity: Implications in smoking | Q39290908 | ||
| Forage plant estrogens | Q39727585 | ||
| Irritant dermatitis from diallylglycol carbonate monomer in the optical industry: clinical and experimental studies of cutaneous tolerance and chemical investigations | Q39807040 | ||
| Sensory irritation by airborne chemicals | Q39870170 | ||
| Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems | Q40286307 | ||
| Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications | Q40294484 | ||
| Acrolein produces nitric oxide through the elevation of intracellular calcium levels to induce apoptosis in human umbilical vein endothelial cells: implications for smoke angiopathy | Q40353627 | ||
| Inhibition of NFkappaB activation and IL-8 expression in human bronchial epithelial cells by acrolein. | Q40471028 | ||
| Effect of acrolein and glutathione depleting agents on thioredoxin | Q40511973 | ||
| Mutagenic activity of major mammalian metabolites of cyclophosphamide toward several genes ofEscherichia coli | Q40840185 | ||
| Molecular analysis of mutations induced by acrolein in human fibroblast cells using supF shuttle vector plasmids | Q41009598 | ||
| Trends in cancer mortality in 15 industrialized countries, 1969-1986. | Q41121211 | ||
| Pharmacogenetics in pediatrics. Implications for practice | Q41371110 | ||
| Sensory irritation structure-activity study of inhaled aldehydes in B6C3F1 and Swiss-Webster mice | Q41594360 | ||
| Validation of two in vitro test systems for estrogenic activities with zearalenone, phytoestrogens and cereal extracts | Q41605659 | ||
| Phosphatase synthesis in Klebsiella (aerobacter) aerogenes growing in continuous culture | Q42064688 | ||
| Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--I. Experimental studies on the urotoxicity of alkylating compounds | Q42270328 | ||
| Induction of cellular glutathione and glutathione S-transferase by 3H-1,2-dithiole-3-thione in rat aortic smooth muscle A10 cells: protection against acrolein-induced toxicity | Q42435942 | ||
| Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells | Q42437541 | ||
| Sensory nerve-mediated immediate nasal responses to inspired acrolein | Q42479913 | ||
| Biosynthesis of mercapturic acids from allyl alcohol, allyl esters and acrolein | Q42924021 | ||
| Irritancy of cyclophosphamide-derived aldehydes (Acrolein, Chloracetaldehyde) and their effect on lymphocyte distribution in vivo: Protective effect of thiols and bisulphite ions | Q43431914 | ||
| Acrolein-induced cytotoxicity in cultured human bronchial epithelial cells. Modulation by alpha-tocopherol and ascorbic acid | Q43852427 | ||
| Genotoxic mechanism for the major acrolein-derived deoxyguanosine adduct in human cells | Q43889165 | ||
| Experimentally induced irritating effects of acrolein on men (author's transl) | Q44136781 | ||
| One-year toxicity of orally administered acrolein to the beagle dog. | Q44226748 | ||
| Immediate sensory nerve-mediated respiratory responses to irritants in healthy and allergic airway-diseased mice | Q44355314 | ||
| Protein adduct-trapping by hydrazinophthalazine drugs: mechanisms of cytoprotection against acrolein-mediated toxicity. | Q44772917 | ||
| The effects of inhalation of organic chemical air contaminants on murine lung host defenses | Q44834801 | ||
| Strong protein adduct trapping accompanies abolition of acrolein-mediated hepatotoxicity by hydralazine in mice | Q44886690 | ||
| Acrolein induces axolemmal disruption, oxidative stress, and mitochondrial impairment in spinal cord tissue. | Q44946130 | ||
| Evaluation of sensory irritation from acrolein-formaldehyde mixtures | Q45206486 | ||
| Induction of thioredoxin reductase as an adaptive response to acrolein in human umbilical vein endothelial cells | Q45225659 | ||
| Acrolein induces oxidative stress in brain mitochondria | Q45238191 | ||
| Mechanism of respiratory effects during exposure of guinea pigs to irritants | Q46214165 | ||
| Acrolein-induced oxygen radical formation | Q46343292 | ||
| Developmental toxicity of acrolein in New Zealand white rabbits | Q46366490 | ||
| Repeated and continuous exposure of laboratory animals to acrolein | Q46565320 | ||
| Regulation of constitutive neutrophil apoptosis by the alpha,beta-unsaturated aldehydes acrolein and 4-hydroxynonenal | Q46616055 | ||
| Acrolein-induced cell death in PC12 cells: role of mitochondria-mediated oxidative stress. | Q46685331 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 447-490 | |
| P577 | publication date | 2008-08-01 | |
| P1433 | published in | Toxicology and Industrial Health | Q7830410 |
| P1476 | title | Acrolein health effects | |
| P478 | volume | 24 |
| Q39085410 | Acrolein Can Cause Cardiovascular Disease: A Review |
| Q33555439 | Acrolein acts as a neurotoxin in the nigrostriatal dopaminergic system of rat: involvement of α-synuclein aggregation and programmed cell death |
| Q33590933 | Acrolein and asthma attack prevalence in a representative sample of the United States adult population 2000-2009. |
| Q37895630 | Acrolein scavengers: reactivity, mechanism and impact on health. |
| Q28069579 | Acrolein-an α,β-Unsaturated Aldehyde: A Review of Oral Cavity Exposure and Oral Pathology Effects |
| Q34131512 | Acrolein-exposed normal human lung fibroblasts in vitro: cellular senescence, enhanced telomere erosion, and degradation of Werner's syndrome protein |
| Q30390927 | Acute effects of acrolein in human volunteers during controlled exposure |
| Q35427617 | Acute systemic accumulation of acrolein in mice by inhalation at a concentration similar to that in cigarette smoke |
| Q50786882 | Analysis of formaldehyde and acrolein in the aqueous samples using a novel needle trap device containing nanoporous silica aerogel sorbent. |
| Q28601204 | Antioxidants as potential medical countermeasures for chemical warfare agents and toxic industrial chemicals |
| Q37048366 | Cigarette smoke component acrolein modulates chromatin assembly by inhibiting histone acetylation |
| Q60955301 | Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes |
| Q39696505 | Endothelial dysfunction and claudin 5 regulation during acrolein-induced lung injury. |
| Q33914376 | Environmental-stress-induced Chromatin Regulation and its Heritability |
| Q51057604 | Functional characterisation and application of an ex vivo perfusion-superfusion system in murine airways. |
| Q48181201 | Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases. |
| Q64266898 | Identification of acrolein metabolites in human buccal cells, blood, and urine after consumption of commercial fried food |
| Q42373718 | Impact of Electronic Cigarettes on the Cardiovascular System |
| Q42014539 | Mass spectrometry-based quantification of myocardial protein adducts with acrolein in an in vivo model of oxidative stress. |
| Q28081607 | Molecular mechanisms of acrolein-mediated myelin destruction in CNS trauma and disease |
| Q51540398 | Proposed Mode of Action for Acrolein Respiratory Toxicity Associated with Inhaled Tobacco Smoke. |
| Q42527938 | Protective Effect of Silymarin against Acrolein-Induced Cardiotoxicity in Mice |
| Q28079909 | Protective effect of silymarin against chemical-induced cardiotoxicity |
| Q37909259 | Protein modification by acrolein: relevance to pathological conditions and inhibition by aldehyde sequestering agents. |
| Q38382568 | Review of the health effects of wildland fire smoke on wildland firefighters and the public |
| Q37877826 | Sensing pulmonary oxidative stress by lung vagal afferents |
| Q38941293 | The use of charcoal in modified cigarette filters for mainstream smoke carbonyl reduction |
| Q37928634 | Toxicology and risk assessment of acrolein in food |
| Q37986932 | Transient receptor potential A1 receptor-mediated neural cross-talk and afferent sensitization induced by oxidative stress: implication for the pathogenesis of interstitial cystitis/bladder pain syndrome |
| Q91636708 | Understanding skin absorption of common aldehyde vapours from exposure during hazardous material incidents |
| Q35553910 | Utility of cell viability assays for use with ex vivo vocal fold epithelial tissue |
Search more.